Mindfulness-Based Group Therapy as a Treatment for Psychiatric Disorders

Overview of the Study

A Swedish study conducted a randomized controlled trial to assess the effectiveness of mindfulness-based group therapy (MGT) in treating psychiatric disorders. The findings revealed no significant differences in outcomes between MGT and standard cognitive behavioural therapy (CBT). This suggests that MGT may serve as an effective treatment option, broadening the scope of care while potentially reducing intervention costs.

Importance of Psychotherapy in Primary Healthcare

Psychotherapy is a crucial element in the management of patients diagnosed with psychiatric disorders, including depression, anxiety, stress, and adjustment issues. These conditions can differ in severity and symptoms, significantly impacting an individual’s mental health and societal well-being. CBT, the most prevalent evidence-based psychotherapy, typically emphasizes problem-solving and action-oriented strategies to combat negative thoughts and attitudes. However, CBT is primarily delivered in one-on-one sessions between a patient and therapist, which can limit accessibility and lead to long waiting times.

Emergence of Mindfulness-Based Group Therapy

In recent years, mindfulness-based group therapy (MGT) has gained attention in several studies. MGT differs from CBT by being conducted in group settings and employing a meditative approach to manage emotions and thoughts. After an initial training period, patients can practice these techniques independently at home, potentially alleviating pressure on healthcare systems and enhancing positive outcomes for a larger number of individuals.

Details of the Current Study

The study, published in European Psychiatry, represents one of the first randomized controlled trials comparing MGT to CBT within a primary care environment. Researchers in Sweden designed an 8-week study conducted in 2012 across 16 primary care centers, involving 215 participants aged 20-64 years, presenting a diverse range of psychiatric symptoms. Participants were divided into two groups: one receiving MGT (the experimental group) and the other receiving CBT (the control group). Some individuals were also prescribed psychotropic medications as needed, but the researchers noted no significant differences in medication use between the groups.

Outcome Measures and Results

The primary metric for evaluating outcomes was the Symptom Distress Checklist (SCL-90), which participants completed before and after the study. This questionnaire assesses symptom intensity across various subscales, including obsessive-compulsive symptoms, depression, and phobic anxiety. Additionally, the Mindful Attention Awareness Scale (MAAS) was utilized to gauge participants’ awareness and understanding of their experiences.

Researchers compared the baseline and post-intervention SCL-90 scores for both groups and calculated changes in reported values. Both groups exhibited a reduction in clinically significant problems following treatment. Statistical analyses indicated no significant differences in observed changes between the two groups, suggesting that MGT is a clinically relevant treatment for psychiatric disorders. Results from the MAAS indicated that participants in both groups achieved enhanced awareness of their experiences.

Limitations and Future Considerations

A limitation acknowledged by the authors was the relatively short follow-up period after treatment, which hindered the ability to confirm the long-term improvement of symptoms. Nonetheless, this study is notable for incorporating an active control group (the CBT group), which strengthened the comparison and interpretation of results.

Implications of Neurophysiological Findings

Brain imaging studies related to MGT suggest that this therapeutic approach can actively alter brain patterns associated with depression and anxiety, leading to both structural and functional changes that enhance emotional regulation. These neurophysiological insights, along with the outcomes of this randomized controlled trial, indicate that MGT has the potential to offer significant benefits to those in need of psychiatric support.

Conclusion

The findings from this study highlight the promise of mindfulness-based group therapy as a viable treatment option for psychiatric disorders, potentially improving access and effectiveness in mental health care.

Written By: Adriano Vissa, PhD Candidate